Which are the causes of Acute lymphocytic leukemia (ALL)?

TL;DR: Acute lymphocytic leukemia (ALL) is caused by genetic mutations in developing white blood cells that lead to uncontrolled production of immature lymphocytes. While the exact trigger for these mutations is usually unknown, the condition is not considered hereditary and is likely the result of complex interactions between rare genetic predispositions and environmental factors.

What causes Acute lymphocytic leukemia (ALL)?

At its core, Acute lymphocytic leukemia (ALL) begins when a single bone marrow cell develops a genetic error. This error interferes with the cell’s ability to mature, causing it to multiply rapidly and crowd out healthy blood cells. Unlike many inherited conditions, Acute lymphocytic leukemia (ALL) is almost always a "somatic" condition, meaning the mutations occur after birth in the individual’s cells, rather than being passed down from parents.

Is there a difference between causes and risk factors?

Yes. A "cause" is the direct mechanism of the disease (the genetic mutation), while a "risk factor" is something that increases the likelihood of those mutations occurring. Most cases of Acute lymphocytic leukemia (ALL) have no identifiable cause. However, researchers have identified several known risk factors that may contribute to the development of the disease:

• Genetic Syndromes: Conditions like Down syndrome (Trisomy 21) significantly increase the risk of developing Acute lymphocytic leukemia (ALL).


• Radiation Exposure: High-dose ionizing radiation (such as exposure from nuclear accidents or high-dose therapeutic radiation) is a known environmental trigger.


• Chemical Exposure: Prolonged exposure to certain chemicals like benzene has been linked to blood cancers.


• Immune System Issues: Certain immune deficiency disorders may slightly elevate risk levels.

Are there specific genetic markers involved?

Scientific research into Acute lymphocytic leukemia (ALL) has uncovered specific chromosomal abnormalities that help doctors classify the disease. For example, the "Philadelphia chromosome" (a translocation between chromosomes 9 and 22) is a well-studied genetic marker that influences treatment approaches. While these markers help define the disease’s behavior, they are generally not inherited, and current research is heavily focused on understanding why these specific cellular errors occur in some people and not others.

Next steps

• Consult a pediatric or adult hematologist-oncologist to discuss specific genetic testing or cytogenetic reports.


• Join the Acute lymphocytic leukemia (ALL) community at DiseaseMaps.org to connect with others sharing their clinical journeys.


• Inquire with your care team about clinical trials that explore targeted therapies based on your specific genetic profile.

Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH National Cancer Institute: Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)


• American Cancer Society: What Causes Acute Lymphocytic Leukemia?


• Orphanet: Acute lymphoblastic leukemia


• Leukemia & Lymphoma Society (LLS): Understanding ALL